← Back to headlines
KalVista Pharmaceuticals Exceeds Q4 Topline Estimates
KalVista Pharmaceuticals announced financial results for its fourth quarter, reporting figures that surpassed topline estimates.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
